Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap?
- 10 June 2010
- journal article
- review article
- Published by Springer Nature in Advances in Therapy
- Vol. 27 (6) , 321-333
Abstract
For over 20 years, the World Health Assembly has recognized diabetes (type 1 and type 2) as a serious threat to national health and economic development and called for action regarding its prevention and control. However, the prevalence of type 2 diabetes continues to rise despite a significant percentage of cases being preventable. Furthermore, data suggest that in many patients diagnosed with type 2 diabetes, glycated hemoglobin (HbA1c) levels remain above the agreed international and national target levels, despite the availability of numerous antihyperglycemic agents, the best intentions of both patient and physician, and the support of the wider healthcare team. Part I of this two-part review considers evidence that seems to suggest there is a knowledge, attitude, and practice (KAP) gap in type 2 diabetes, and that although theoretical knowledge of how type 2 diabetes should be managed exists, the attitude of patients and healthcare professionals may influence the practicalities of implementing life-enhancing changes for patients living day-to-day with the condition. Here, we consider why there may be a KAP gap, how type 2 diabetes is currently being assessed and managed, and whether these current management approaches remain valid in the light of recent studies evaluating the impact of lowering current target HbA1c levels. This article also explores how encouraging patients to self-manage their disease, as well as engaging all stakeholders in the necessary behavioral changes, can positively influence the long-term treatment outcomes of patients with type 2 diabetes.Keywords
This publication has 36 references indexed in Scilit:
- Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort studyThe Lancet, 2010
- Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary preventionBMC Public Health, 2009
- Multifaceted Determinants for Achieving Glycemic ControlDiabetes Care, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Targets and tactics: the relative importance of HbA1c, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetesInternational Journal Of Clinical Practice, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Type 2 diabetes: A well-characterised but suboptimally controlled disease. Can we bridge the divide?Diabetes & Metabolism, 2008
- European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)European Heart Journal, 2007
- Incretin Mimetics and DPP-IV Inhibitors: New Paradigms for the Treatment of Type 2 DiabetesThe Journal of the American Board of Family Medicine, 2006